9 search results for “malaria” in the Public website
-
Mapping Medieval Malaria
This research project studies the distribution and impact of medieval malaria in the Netherlands.
-
First clinical trial with genetically modified malaria vaccine completed
In an innovative study, Radboudumc and LUMC jointly tested a candidate vaccine based on a genetically weakened malaria parasite. The results of this clinical trial, published in Science Translational Medicine, show that the vaccine is safe and elicits a defense response against a malaria infection.
-
Researchers discover how malaria parasite survives in mosquitoes
Researchers from Leiden University Medical Center (LUMC) have discovered how malaria parasites escape the immune system of mosquitoes. The so-called QC enzyme changes proteins on the outside of the malaria parasite such that the immune cells are unable to recognise the parasite. As a result, the parasite…
-
Testing of a malaria vaccine gets the green light
Researchers at Leiden University Medical Center (LUMC) and Radboud university medical center have been given the green light to deliberately infect volunteers with malaria in order to test a highly promising vaccine on them.
-
Archaeologist Rachel Schats on Science071 about malaria in medieval low countries
Osteoarchaeologist Rachel Schats investigates traces of malaria in old human skeletons. Even though the disease cannot be spotted directly in bone material, you may find traces of it, for example through porosity caused by anemia, linked to malaria. Rachel was a guest in the programme Science071 on…
-
2 new Veni-grants: investigating malaria in the Middle Ages and coinage in Rome
Two researchers at the Faculty of Archaeology have received a Veni award from the Netherlands Organisation for Academic Research (NWO). This award offers promising young researchers the opportunity to further develop their ideas for a period of three years.
-
Towards an Archaeology of Malaria
International Symposium on Malaria Studies
-
Open letter is successful: The Lancet withdraws controversial Covid-19 publication
The leading medical journal The Lancet has withdrawn a controversial publication on the antimalarial drug hydroxychloroquine. The reason for this is the open letter to The Lancet that over a hundred scientists signed, including Richard Gill, Leiden Professor emeritus of Mathematical statistics.
-
Werken aan een effectiever malariavaccin
In het Leids Universitair Medisch Centrum wordt gewerkt aan de ontwikkeling van een nieuw malariavaccin dat effectiever is dan de huidige vaccins.